Search

Search Constraints

You searched for: Author/Creator Overman, Michael

Search Results

1. Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma. Issue 6 (June 2020)

2. Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies. Issue 4 (24th April 2020)

3. Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial. Issue 5 (20th May 2022)

4. Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers. Issue 2 (2nd February 2022)

5. Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma. (9th June 2020)

6. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Issue 17 (31st May 2016)

8. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Issue 3 (26th March 2023)

9. Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer. Issue 1 (28th February 2020)

10. Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer. (5th June 2020)